FDA issues guidance to increase mobile patient monitoring, imaging options

The Food and Drug Administration yesterday issued guidance allowing patients to use certain non-invasive fetal and maternal monitoring devices in the home during the COVID-19 emergency to reduce the need for in-clinic visits. FDA also issued guidance to expand mobile and portable imaging options to diagnose and monitor treatment of lung disease patients with COVID-19 during the emergency.